Skip to Main Content

Paper Details

Commentary on "Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study".
mBio
0
2022
COVID-19, CoronaVirus, Patients, SARS, SARS-CoV-2, convalescent plasma, immunocompromised, patients
Author NameAffiliation
Michael J JoynerMayo Clinicgrid.66875.3a
Nigel PanethMichigan State University, College of Human Medicine
Nigel PanethMichigan State University, College of Human Medicine
Nigel PanethMichigan State University, College of Human Medicine
Nigel PanethMichigan State University, College of Human Medicine
  • 1 - 5

Datasets

Release 1.2